Cargando…
Antiviral Activity of Chitosan Nanoparticles Encapsulating Curcumin Against Hepatitis C Virus Genotype 4a in Human Hepatoma Cell Lines [Corrigendum]
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7943537/ https://www.ncbi.nlm.nih.gov/pubmed/33707947 http://dx.doi.org/10.2147/IJN.S308439 |
Ejemplares similares
-
Antiviral Activity of Chitosan Nanoparticles Encapsulating Curcumin Against Hepatitis C Virus Genotype 4a in Human Hepatoma Cell Lines
por: Loutfy, Samah A, et al.
Publicado: (2020) -
Antiviral Activity of Chitosan Nanoparticles Encapsulating Curcumin Against Hepatitis C Virus Genotype 4a in Human Hepatoma Cell Lines [Retraction]
Publicado: (2022) -
Factors determining the stability, size distribution, and cellular accumulation of small, monodisperse chitosan nanoparticles as candidate vectors for anticancer drug delivery: application to the passive encapsulation of [(14)C]-doxorubicin [Corrigendum]
Publicado: (2016) -
Synthesis, Characterization, and in vitro Evaluation of Curcumin-Loaded Albumin Nanoparticles Surface-Functionalized with Glycyrrhetinic Acid [Corrigendum]
Publicado: (2021) -
Corrigendum in “Virus C genotype predisposes to primary hypothyroidism during interferon-α treatment for chronic hepatitis C”
por: Pavan, Maria Helena Postal, et al.
Publicado: (2013)